Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
JMIR Formative Research|October 28, 2020
Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort StudySanna Iivanainen, Tuomo Alanko, Pia Vihinen, et al.
International Journal of Cancer|January 22, 2002
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanomaJohanna Nikkola, Pia Vihinen, Tatyana Vlaykova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2005
High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanomaJohanna Nikkola, Pia Vihinen, Meri-Sisko Vuoristo, et al.
Head & Neck|November 23, 2005
Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancerMarjaana Luukkaa, Pia Vihinen, Pauliina Kronqvist, et al.
Acta Oncologica (Stockholm, Sweden)|April 24, 2018
Selective internal radiation therapy (SIRT) as treatment for hepatic metastases of uveal melanoma: a Finnish nation-wide retrospective experienceSanni Tulokas, Hanna Mäenpää, Erno Peltola, et al.
Anticancer Research|December 7, 2016
Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast CancerLeena Tiainen, Minna Tanner, Outi Lahdenperä, et al.
Clinical Breast Cancer|April 29, 2019
Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast CancerLeena Tiainen, Mari Hämäläinen, Tiina Luukkaala, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2014
Benefit of adjuvant interferon alfa-2b (IFN-α) therapy in melanoma patients with high serum MMP-8 levelsPia Vihinen, Taina Tervahartiala, Timo Sorsa, et al.
Clinical & Experimental Metastasis|September 1, 2007
Serum angiogenin levels predict treatment response in patients with stage IV melanomaPia Vihinen, Minna Kallioinen, Meri-Sisko Vuoristo, et al.
BMC Cancer|March 12, 2024
Neuropilin-1 and placental growth factor as prognostic factors in metastatic breast cancerNiina Mäenpää, Leena Tiainen, Mari Hämäläinen, et al.
Pageof 4